Criminal Investigation | June 5, 2019

Opioid Manufacturer Insys Therapeutics Agrees to Enter $225 Million Global Resolution of Criminal and Civil Investigations


As part of the civil resolution, lnsys agreed to pay $195 million to settle allegations that it violated the False Claims Act. As part of the criminal resolution, lnsys will enter into a deferred prosecution agreement with the government, lnsys's operating subsidiary will plead guilty to five counts of mail fraud, and the company will pay a $2 million fine and $28 million in forfeiture.